GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Indrayani Biotech Ltd (BOM:526445) » Definitions » Debt-to-Revenue

Indrayani Biotech (BOM:526445) Debt-to-Revenue : 0.00 (As of Dec. 2023)


View and export this data going back to 1994. Start your Free Trial

What is Indrayani Biotech Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Indrayani Biotech's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Indrayani Biotech's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₹0 Mil. Indrayani Biotech's annualized Revenue for the quarter that ended in Dec. 2023 was ₹1,564 Mil. Indrayani Biotech's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.00.


Indrayani Biotech Debt-to-Revenue Historical Data

The historical data trend for Indrayani Biotech's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indrayani Biotech Debt-to-Revenue Chart

Indrayani Biotech Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Debt-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only N/A 0.28 0.74 0.31 0.43

Indrayani Biotech Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.36 - 0.55 -

Competitive Comparison of Indrayani Biotech's Debt-to-Revenue

For the Specialty Business Services subindustry, Indrayani Biotech's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Indrayani Biotech's Debt-to-Revenue Distribution in the Business Services Industry

For the Business Services industry and Industrials sector, Indrayani Biotech's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Indrayani Biotech's Debt-to-Revenue falls into.



Indrayani Biotech Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Indrayani Biotech's Debt-to-Revenue for the fiscal year that ended in Mar. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(344.996 + 356.863) / 1629.279
=0.43

Indrayani Biotech's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue=Total Debt / Revenue
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Revenue
=(0 + 0) / 1563.708
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Dec. 2023) Revenue data.


Indrayani Biotech Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Indrayani Biotech's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Indrayani Biotech (BOM:526445) Business Description

Traded in Other Exchanges
N/A
Address
Module No. 32-33, Block 1, 3rd Floor, SIDCO Electronic Complex, Thiru-vi-ka Industrial Estate, Guindy, Chennai, TN, IND, 600032
Indrayani Biotech Ltd operates in the Tri-segment i.e. Foods & Hospitality, Engineering and Healthcare divisions. The company generates its revenue from the sale of food, beverages, sale of Milk products & related services, sale of Engineering products & others, and sale of services. The majority of its revenue is generated from the sale of Milk products & related services.

Indrayani Biotech (BOM:526445) Headlines

No Headlines